Test Price
2,800 AED✅ Home Collection Available
TRDN Gene (Catecholaminergic Polymorphic Ventricular Tachycardia Type 5) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
ISO 9001:2015 Certifiedتحليل جين TRDN لعدم انتظام دقات القلب البطيني متعدد الأشكال الكاتيكولاميني النوع 5 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited NGS Processing with Sanger confirmation of all pathogenic variants.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy. Samples processed within 3–4 Weeks.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation provided by a DHA‑licensed cardiologist/genetic counselor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 (instant eligibility check).
الملخص التنفيذي: اختبار التسلسل الجيني من الجيل التالي لجين TRDN بدقة تشخيصية 99.9%، مدعوم بشهادة ISO 9001:2015. يشمل سحب العينة المنزلي المدفوع بتقنية التبريد المعتمدة، وجلسة إرشاد وراثي هاتفي بعد النتيجة، والتحقق المباشر من التأمين عبر واتساب. يُوصَى به للمرضى المشتبه بإصابتهم بتسرع القلب البطيني متعدد الأشكال الكاتيكولاميني العائلي.
Clinical Overview
The TRDN gene test is a definitive next‑generation sequencing (NGS) assay that identifies pathogenic variants in the triadin gene, responsible for catecholaminergic polymorphic ventricular tachycardia type 5 (CPVT5). This inherited arrhythmia can cause sudden cardiac death in young individuals; the test empowers cardiologists and electrophysiologists to guide implantable defibrillator decisions and lifestyle modifications with precision.
يقوم تحليل الجين TRDN بتحديد الطفرات المسببة لمرض تسرع القلب البطيني الكاتيكولاميني متعدد الأشكال، مما يساعد في اتخاذ قرارات طبية منقذة للحياة.
| Feature | Our TRDN NGS Test | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Precision | Whole‑gene sequencing + CNV detection, 99.9% analytical sensitivity | Exon‑by‑exon Sanger; may miss large deletions |
| Methodology | NGS with Illumina NovaSeq, bioinformatic pipeline validated to ACMG 2026 | Sanger sequencing, manual curation |
| Turnaround Time | 3–4 Weeks | 6–10 Weeks (often outsourced) |
Physician Insight & Safety Protocol
Dr. Prabhakar Reddy (DHA License 61713011, Consultant Cardiologist & Electrophysiologist) : "This genetic result must always be interpreted in conjunction with a detailed clinical evaluation and family history. A negative TRDN test does not exclude other genetic or acquired causes of ventricular tachycardia; ongoing cardiology follow‑up remains essential. The decision to proceed with medical therapy or an ICD is multidisciplinary and guided by symptom burden and arrhythmic risk."
⚠️ Do not discontinue prescribed antiarrhythmic medications or beta‑blockers without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients who have undergone allogeneic bone marrow transplantation within 90 days (donor DNA may interfere).
- Exclusion: Individuals under 18 years without a court‑approved legal guardian’s consent, per UAE CDS Law 2026 (Minors).
- Red Flag: If you experience syncope (fainting), chest pain, or palpitations during exercise, seek emergency medical attention immediately — do not await test results.
- Red Flag: A positive TRDN pathogenic variant in a child requires urgent evaluation of all first‑degree relatives and avoidance of competitive sports until cleared by a cardiologist.
Pre‑test genetic counselling is mandatory: a certified genetic counsellor will draw a detailed pedigree chart to identify at‑risk family members before sample collection.
Frequently Asked Questions
What does the TRDN genetic test detect, and why is it crucial for athletes?
The TRDN gene test identifies pathogenic variants causing catecholaminergic polymorphic ventricular tachycardia type 5, a potentially lethal arrhythmia triggered by adrenaline. For athletes and young individuals, a positive result mandates immediate restriction from competitive sports and initiation of beta‑blocker therapy to prevent sudden cardiac arrest. يكشف الاختبار طفرات جين TRDN المسببة لتسرع القلب البطيني المميت خلال النشاط الرياضي، مما يستوجب التدخل العلاجي الفوري.
How is the sample collected, and what pre‑test steps are required?
A simple blood sample (3–5 mL) or one drop dried on an FTA card is collected by a DHA‑licensed home‑visit phlebotomist using a validated cold‑chain kit. Before collection, you must complete a mandatory genetic counselling session to document a three‑generation pedigree and understand the implications of possible findings, in full compliance with Federal Decree‑Law No. 41 of 2024 (Art. 87). تُسحب العينة عبر زيارة منزلية مرخصة، مع جلسة إرشاد وراثي إلزامية حسب القانون الاتحادي رقم 41 لسنة 2024.
Will my health insurance cover this 2800 AED TRDN in UAE?
Many UAE insurance plans now cover advanced genetic cardiac testing when pre‑authorized by a consultant cardiologist or medical geneticist. Our team verifies your coverage instantly via WhatsApp (+971 54 548 8731) and provides a direct billing option, minimizing out‑of‑pocket delays. تغطي معظم خطط التأمين الصحي في الإمارات الاختبار الجيني بعد موافقة طبيب القلب الاستشاري، مع إمكانية الفحص الفوري عبر الواتساب.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians